228 related articles for article (PubMed ID: 32594785)
1. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
[TBL] [Abstract][Full Text] [Related]
2. Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film.
Sedlak L; Świerczyńska M; Borymska W; Zych M; Wyględowska-Promieńska D
BMC Ophthalmol; 2021 Sep; 21(1):319. PubMed ID: 34470600
[TBL] [Abstract][Full Text] [Related]
3. Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film.
Sedlak L; Zych M; Wojnar W; Wyględowska-Promieńska D
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336766
[No Abstract] [Full Text] [Related]
4. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride.
Ishibashi T; Yokoi N; Kinoshita S
J Glaucoma; 2003 Dec; 12(6):486-90. PubMed ID: 14646684
[TBL] [Abstract][Full Text] [Related]
5. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254
[TBL] [Abstract][Full Text] [Related]
6. Effect of timolol with and without preservative on the basal tear turnover in glaucoma.
Kuppens EV; de Jong CA; Stolwijk TR; de Keizer RJ; van Best JA
Br J Ophthalmol; 1995 Apr; 79(4):339-42. PubMed ID: 7742279
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response.
Nuzzi R; Finazzo C; Cerruti A
Int Ophthalmol; 1998; 22(1):31-5. PubMed ID: 10090446
[TBL] [Abstract][Full Text] [Related]
8. Preservative-free
Duru Z; Ozsaygili C
Cutan Ocul Toxicol; 2020 Mar; 39(1):21-24. PubMed ID: 31615279
[No Abstract] [Full Text] [Related]
9. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia.
Miyake K; Ota I; Ibaraki N; Akura J; Ichihashi S; Shibuya Y; Maekubo K; Miyake S
Arch Ophthalmol; 2001 Mar; 119(3):387-94. PubMed ID: 11231772
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications.
Liu X; Yu FF; Zhong YM; Guo XX; Mao Z
Chin Med J (Engl); 2015 Sep; 128(18):2444-9. PubMed ID: 26365960
[TBL] [Abstract][Full Text] [Related]
11. [Modification of tear film break-up time by beta blocker eyedrops without preservatives].
Marquardt R; Schubert T
Klin Monbl Augenheilkd; 1991 Aug; 199(2):75-8. PubMed ID: 1960936
[TBL] [Abstract][Full Text] [Related]
12. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.
Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826
[TBL] [Abstract][Full Text] [Related]
13. Chronic topical eye preservative-free beta-blocker therapy effect on the ocular surface in glaucomatous patients.
Campagna P; Macri A; Rolando M; Calabria G
Acta Ophthalmol Scand Suppl; 1997; (224):53. PubMed ID: 9589739
[No Abstract] [Full Text] [Related]
14. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits.
Pisella PJ; Fillacier K; Elena PP; Debbasch C; Baudouin C
Ophthalmic Res; 2000; 32(1):3-8. PubMed ID: 10657748
[TBL] [Abstract][Full Text] [Related]
15. Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride.
Li C; Song Y; Luan S; Wan P; Li N; Tang J; Han Y; Xiong C; Wang Z
PLoS One; 2012; 7(3):e33688. PubMed ID: 22438984
[TBL] [Abstract][Full Text] [Related]
16. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
Jee D; Park SH; Kim MS; Kim EC
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
[TBL] [Abstract][Full Text] [Related]
18. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
19. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells.
De Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C
Curr Eye Res; 2000 Feb; 20(2):85-94. PubMed ID: 10617908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
